SAGIMET BIOSCIENCES INC. Insider George Buys 20K Shares as Stock Climbs 8.7% to 52‑Week High, Signaling Confidence Ahead of Dermatology Trial
Insider buying surges at SAGIMET as Kemble George snaps up shares amid an 8.68% price jump, signaling confidence in its Phase‑3 dermatology trial and strong cash runway.
3 minutes to read